Related Experiment Video
Updated: Jul 25, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
A patient with rapidly growing axillary masses
Jurga Marshall1, Priya Bhave, Mirela Bruza-Augatis
1Jurga Marshall is an assistant professor in the PA program at Seton Hall University in Nutley, N.J., and practices in the ED at St. Mary's General Hospital in Passaic, N.J. Priya Bhave practices at Union Square Medical Associates in Elizabeth, N.J. Mirela Bruza-Augatis is an adjunct professor in the PA program at Seton Hall University. Christine Fernandez is medical director at Seton Hall University. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Melanoma of unknown primary (MUP) site, diagnosed in 3.2% of cases, presents as metastatic melanoma in lymph nodes without a detectable primary tumor. Management follows standard staging and treatment protocols for known primary melanomas.
Area of Science:
- Oncology
- Dermatology
- Pathology
Background:
- Melanoma is a significant cancer, with approximately 85,000 diagnoses annually in the U.S.
- A small percentage (3.2%) of melanomas are diagnosed without a discernible primary tumor site.
- Melanoma of unknown primary (MUP) site presents a diagnostic challenge.
Purpose of the Study:
- To describe a clinical case of metastatic melanoma with no known primary site.
- To highlight the diagnostic and staging considerations for MUP.
- To emphasize that management is consistent with known primary melanoma.
Main Methods:
- Case presentation of a patient with rapidly growing axillary masses.
- Diagnostic workup to identify metastatic melanoma.
- Staging of the MUP based on established criteria.
Main Results:
- The patient presented with metastatic melanoma in the lymph nodes, with no identifiable primary melanoma.
- The MUP was staged as either Level III or IV.
- This case illustrates a common presentation of MUP.
Conclusions:
- Melanoma of unknown primary site requires careful evaluation and staging.
- Management strategies for MUP are aligned with those for melanomas of known primary site.
- Prompt diagnosis and appropriate staging are crucial for effective patient care.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Assessing Body Temperature - Axilla
Step 1: Perform hand hygiene and put on clean gloves to maintain infection control and prevent cross-contamination.
Step 2: Prepare the patient by explaining the procedure to ensure understanding and cooperation. Ensure privacy, expose the axilla, and inform the patient that minimal movement is crucial for an accurate reading.
Step 3: Adjust the patient’s clothing to expose only the axilla. It minimizes...
Abnormal Proliferation
Aneurysm II: Clinical Manifestations and Diagnostic Studies